RaQualia selects Miner3D for its visual data analysis platform

RaQualia Pharma will use Miner3D as its main R&D data analytics platform.  

RaQualia, a pharmaceutical research and development company, is a spin-off of drug maker giant Pfizer. The company focuses on pain and gastrointestinal therapeutic areas and manages six drug discovery programs.  

Miner3D helps RaQualia’s scientists and researchers to better understand vast amounts of scientific data, improve leads identification and speed up research and development processes.

Twitter icon
Google icon icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Analysis and opinion

Robert Roe looks at research from the University of Alaska that is using HPC to change the way we look at the movement of ice sheets


Robert Roe talks to cooling experts to find out what innovation lies ahead for HPC users

Analysis and opinion